# A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization

> **NCT02533791** · PHASE1 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 110 (actual)

## Conditions studied

- Ebola Virus Disease

## Interventions

- **BIOLOGICAL:** 4×10^10vp/1ml Ebola Zaire vaccine (Ad5-EBOV)
- **BIOLOGICAL:** 1.6×10^11vp/2ml Ebola Zaire vaccine (Ad5-EBOV)
- **BIOLOGICAL:** placebo

## Key facts

- **NCT ID:** NCT02533791
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-09
- **Final completion:** 2015-10
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2015-10-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02533791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02533791, "A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02533791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*